Essity B 235.9 (+4.3 SEK) on 29-Sep-2023 17:29
Select region

Global Site

USA USA Germany Germany Mexico Mexico Netherlands Netherlands France France Sweden Sweden Italy Italy Spain Spain

Did you mean

    Advanced search

    Quick results

    View all results

    These might help

    Pressemitteilungen zum Unternehmen

    Neuigkeiten über das Unternehmen

    Kalender

    Essity logo
    Marken

    Unternehmen

    Unternehmen

    Essity auf einen Blick
    Purpose und Vision Unsere Überzeugungen Unsere Geschichte
    Essity Deutschland
    Essitys Geschäft
    Health & Medical Consumer Goods Professional Hygiene Markt und Trends E-Commerce
    Breaking Barriers to Well-Being
    Hygiene ist mehr Podcast Tabufrei Schulhygiene-Projekt Menopause

    Marken

    Marken

    Nachhaltigkeit

    Nachhaltigkeit

    Das Wohlbefinden von Menschen und Gesellschaften verbessern
    Umweltauswirkungen auf unseren Planeten reduzieren
    Nachhaltigkeitsberichterstattung, Governance und Daten
    Gastbeitragsreihe
    Deutsche Nachhaltigkeitsbeispiele
    Panel Nachhaltiger Konsum
    Strohzellstoff
    Green Response Study

    Innovation

    Innovation

    Produkte und Lösungen
    Digitalisierung
    Essity Ventures

    Karriere

    Karriere

    Stellenangebote
    Arbeiten bei Essity
    Einsatz für unsere Mitarbeitenden Mitarbeiter-Vielfalt Weiterbildung und Entwicklung Warum für Essity arbeiten? Barrier Breakers
    Schüler, Studierende & Absolvierende
    Absolvierende Studierende Praktika Ausbildung
    Karrieregeschichten
    Alumni Netzwerk
    Vernetze Dich mit uns
    Total Rewards

    Presse

    Presse

    Pressemitteilungen Global
    Pressemitteilungen Deutschland
    Weitere Neuigkeiten
    Bilder & Videos
    Essity in den sozialen Medien
    Publikationen
    Home
    Presse
    Pressemitteilungen Global
    2023
    Presse
    Pressemitteilungen Global Pressemitteilungen Deutschland Weitere Neuigkeiten Bilder & Videos Essity in den sozialen Medien Publikationen

    April 27, 2023

    Interim Report Quarter 1, 2023

    JANUARY 1 – MARCH 31, 2023
    (compared with the corresponding period a year ago)

    • Net sales increased 25.1% to SEK 42,926m (34,301)
    • Sales growth, including organic sales growth and acquisitions, amounted to 17.2%, of which volume accounted for
      -2.6%, price/mix for 18.6% and acquisitions for 1.2%.
    • Operating profit before amortization of acquisition-related intangible assets (EBITA) increased to SEK 4,445m (1,663)
    • Adjusted EBITA increased to SEK 4,358m (2,826) and the adjusted EBITA margin to 10.2% (8.2)
    • Profit for the period increased to SEK 2,703m (521)
    • Earnings per share increased to SEK 3.79 (0.44) and adjusted earnings per share to SEK 3.97 (2.72)
    • Cash flow from current operations amounted to SEK 849m (1,070)
    • Return on capital employed increased to 12.9% (5.3) and the adjusted return on capital employed to 12.7% (9.0)
    • Essity is initiating a strategic review of its ownership of Vinda and the Consumer Tissue Private Label Europe business

    CEO’S COMMENTS

    Strong start to the year for both sales and profitability

    Essity’s sales and profitability performed positively in the first quarter, primarily due to attractive customer offerings and higher sales prices to compensate for the cost increase. As part of our efforts to increase the company’s long-term value creation, we have decided to initiate a strategic review of our ownership of Vinda and the Consumer Tissue Private Label Europe business with the aim of reducing Consumer Tissue’s share of the company’s total sales.

    Higher sales and profitability

    Essity’s sales growth amounted to just over 17% for the first quarter of 2023, compared with the corresponding period of 2022. Sales prices were higher and the product mix better in all business areas. Volumes declined somewhat on account of the company’s prioritization of higher profitability ahead of volume. Furthermore, volumes were negatively impacted by ongoing efforts to exit the Russian market and the discontinuation of the baby diaper business in Latin America. Adjusted EBITA increased by 54% and the adjusted EBITA margin by 2 percentage points to 10.2%. Profit for the period increased to approximately SEK 2.7bn and earnings per share to SEK 3.79.

    Strategic review

    Essity continuously evaluates the product portfolios within the company’s three business areas, Health & Medical, Consumer Goods and Professional Hygiene, to achieve increased long-term value creation. In line with this, Essity is initiating a strategic review of the company’s ownership of Vinda and the Consumer Tissue Private Label Europe business, with the aim of reducing Consumer Tissue’s share of the company’s total sales. The strategic review includes exploring different options and may result in divestments, although no such decisions have yet been taken.

    Important step toward net zero emissions

    During the first quarter of the year, Essity announced several important steps toward net zero emissions. We are first to produce tissue in a CO2-free production process using renewable hydrogen and to produce high-quality tissue from agricultural waste. We have also entered an exclusive partnership to develop a new tissue making process with the aim of significantly reducing energy consumption, CO2 emissions and water consumption. Essity has been included in S&P Global Sustainability Yearbook and been awarded a place on CDP’s 2022 Supplier Engagement Leaderboard.

    On the path toward achieving return target

    The company’s adjusted return on capital employed increased to 12.7% for the first quarter of 2023. We are working in a focused manner – through innovation, value-generating customer offerings, strong brands, efficiency improvements and sustainable, profitable growth – to achieve our target of an adjusted return on capital employed of more than 17% by 2025.

    Magnus Groth
    President and CEO

     

    FUTURE REPORTS
    In 2023, interim reports will be published on July 20 and October 26. The year-end report for 2023 will be published on January 25, 2024.

    INVITATION TO PRESENTATION OF THE INTERIM REPORT FOR QUARTER 1, 2023
    In conjunction with publication, a telephone and web presentation will be held at 09:00 CET, where President and CEO Magnus Groth will present and answer questions.

    Presentation
    Date: Thursday, April 27, 2023

    Time: 09:00 CET
    Link to web presentation: https://essity.videosync.fi/2023-04-27
    Telephone: UK: +44 (0) 33 0551 02 00, USA: +1 786 697 35 01, SWE: +46 (0) 8 505 204 24. Please call in well in advance of the start of the presentation. Indicate: "Essity".

    Stockholm April 27, 2023
    Essity Aktiebolag (publ)



    Magnus Groth
    President and CEO

     

    For further information, please contact:
    Fredrik Rystedt, CFO and Executive Vice President, +46 (0) 8 788 51 31
    Johan Karlsson, Vice President Investor Relations, Group Function Finance, +46 (0) 70 511 15 81
    Per Lorentz, Vice President Corporate Communications, Group Function Communications, +46 (0) 73 313 30 55


    NB:
    This report has not been reviewed by the company’s auditors.

     

    This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. This report has been prepared in both Swedish and English versions. In case of variations in the content between the two versions, the Swedish version shall govern. The information was submitted for publication, through the agency of Karl Stoltz, Media Relations Director, at 07:00 CET on April 27, 2023.

    Press release (PDF)
    Back to press releases

    Share this

    Essity logo
    Marken Unternehmen Breaking Barriers Kontaktiere uns
    Datenschutzrichtlinie Cookies Rechtliche Hinweise & Datenschutz

    Tel +49 621 778-0

    email info.deutschland@essity.com

    Essity GmbH, Sandhofer Straße 176, 68305 Mannheim

    © Essity Deutschland